Ann: Phase I Clinical Trial Dosing Update No 3, page-26

  1. 1,430 Posts.
    lightbulb Created with Sketch. 190
    Kyriaco he will keep reporting you so you get banned ignore him.

    1. Next 1-2 months company news flow continues and finialised safety
    2. submission of IND and fast track with FDA.
    3. Company preparing already for phase 2 this year for cardiovascular indication
    4. AGN 2 months to go until results and reconfirmation of NYR mechanism of action of reducing calcium influx into neurons protects the human brain which will end up the same as NA-1
    5. Non dilutive funding for TBI with US defence force

    There is a lot coming in the next 2-3 months ignore him. AGN will become 200-300 million dollar company on its results coming up NYR will follow. NYR is significantly undervalued our time will come


    Last edited by Bendunstan: 22/05/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
33.0¢
Change
-0.010(2.94%)
Mkt cap ! $69.60M
Open High Low Value Volume
34.0¢ 34.3¢ 32.5¢ $195.9K 589.3K

Buyers (Bids)

No. Vol. Price($)
2 14970 33.0¢
 

Sellers (Offers)

Price($) Vol. No.
33.5¢ 20100 1
View Market Depth
Last trade - 15.29pm 25/07/2025 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.